New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study

New disease-modifying treatments have recently been approved for 5q spinal muscular atrophy (SMA) and early treatment has been associated with a better clinical outcome. Accordingly, new-born screening (NBS) for SMA should be implemented to ensure early diagnosis of affected individuals. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gailite, Linda, Sterna, Olga, Konika, Maija, Isakovs, Aleksejs, Isakova, Jekaterina, Micule, Ieva, Setlere, Signe, Diriks, Mikus, Auzenbaha, Madara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883930/
https://www.ncbi.nlm.nih.gov/pubmed/35225937
http://dx.doi.org/10.3390/ijns8010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883930/
https://www.ncbi.nlm.nih.gov/pubmed/35225937
http://dx.doi.org/10.3390/ijns8010015

Ejemplares similares